An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients
D853AC00001
Phase 1 other active
Quick answer
An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients for Breast Cancer is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active